Table 2.
Semi-quantitative evaluation of PAX7, PAX9, and SHH gene signals in cleft-affected palatine mucosa and controls
| Patient’s No | PAX7 | PAX9 | SHH | ||||||
|---|---|---|---|---|---|---|---|---|---|
| E | CT | END | E | CT | END | E | CT | END | |
| 1 | + / + + | 0 | 0 | 0/ + | 0 | 0 | 0 | 0 | 0 |
| 2 | 0/ + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | + + / + + + | 0/ + | 0 | 0/ + | 0 | 0 | + / + + | 0 | 0 |
| 4 | + + + / + + + + | + + | + | + + / + + + | 0 | 0 | 0 | 0 | 0 |
| 5 | + + + | + | 0 | + + / + + + | 0 | 0 | 0/ + | 0 | 0 |
| 6 | + + + / + + + + | + + / + + + | + / + + | + + | 0 | 0 | 0/ + | 0 | 0 |
| 7 | + / + + | 0/ + | 0 | 0/ + | 0 | 0 | 0 | 0 | 0 |
| 8 | + + + / + + + + | + + / + + + | + / + + | + + / + + + | 0 | 0 | + / + + | 0 | 0 |
| 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 10 | + + + / + + + + | 0/ + | 0 | + + / + + + | 0 | 0 | + + / + + + | 0 | 0 |
| 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 12 | + + + | 0/ + | 0 | + + | 0 | 0 | 0 | 0 | 0 |
| 13 | + + / + + + | 0 | 0 | 0 | 0 | 0 | 0/ + | 0 | 0 |
| 14 | + + + / + + + + | + / + + | 0 | + + / + + + | 0 | 0 | 0 | 0 | 0 |
| 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Median | 2.5 | 0.5 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Q1–Q3 | 0.5–3.5 | 0.0–1.5 | 0.0–0.0 | 0.0–2.5 | 0.0–0.0 | 0.0–0.0 | 0.0–0.5 | 0.0–0.0 | 0.0–0.0 |
| Control | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Abbreviations: No. number, E epithelium, CT connective tissue, END endothelium